Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-42,735
Closed -$5.82M 311
2025
Q4
$5.82M Sell
42,735
-1,320
-3% -$190K 0.4% 73
2025
Q3
$6.5M Sell
44,055
-119
-0.3% -$16.5K 0.47% 66
2025
Q2
$5.71M Sell
44,174
-479
-1% -$58K 0.46% 70
2025
Q1
$5.33M Buy
44,653
+1,812
+4% +$225K 0.49% 68
2024
Q4
$4.97M Buy
42,841
+628
+1% +$79.4K 0.5% 68
2024
Q3
$5.7M Buy
42,213
+713
+2% +$95.4K 0.57% 62
2024
Q2
$5.63M Buy
41,500
+2,021
+5% +$275K 0.56% 61
2024
Q1
$5.1M Buy
39,479
+4,785
+14% +$578K 0.53% 68
2023
Q4
$3.97M Buy
+34,694
New +$3.46M 0.49% 71

Other funds holding XYL

First American Trust's XYL Position: Q1 2026 in Review

First American Trust sold out of Xylem (XYL) in Q1 2026, closing a stake of 42,735 shares — an estimated $5.82M sold.

First American Trust first reported a position in XYL in Q4 2023 and held it in 9 quarters. The position peaked at $6.5M in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • First American Trust reported no remaining Xylem position as of Q1 2026 after selling out during the quarter.
  • First American Trust sold 42,735 Xylem shares in Q1 2026, an estimated $5.82M.
  • First American Trust first reported a position in Xylem in Q4 2023 and held it in 9 quarters.
  • First American Trust's Xylem position peaked at $6.5M in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on First American Trust's 13F filing for Q1 2026, filed 12 May 2026.